Notably, IGF2BP1 knockdown, but not IGF2BP2/3 knockdown, significantly reduced Soga1 mRNA and protein levels in CRC cells (Figure 4J–N). This evidence concerns the gene IGF2BP2 and colorectal carcinoma.